BACK TO TOP
KSE100
146,480.14
-11015.96
(-6.99%)
KSE100PR
45,712.51
-3445.88
(-7.01%)
ALLSHR
88,401.14
-5825.86
(-6.18%)
KSE30
44,996.50
-3333.70
(-6.90%)
KMI30
210,039.40
-14647.93
(-6.52%)
BKTI
42,364.50
-3125.45
(-6.87%)
OGTI
31,480.48
-602.98
(-1.88%)
KMIALLSHR
57,315.72
-3523.37
(-5.79%)
PSXDIV20
66,760.62
-4634.57
(-6.49%)
UPP9
50,951.43
-4450.55
(-8.03%)
NITPGI
38,682.36
-2782.91
(-6.71%)
NBPPGI
42,600.30
-2936.75
(-6.45%)
MZNPI
26,079.35
-1864.71
(-6.67%)
JSMFI
38,472.39
-3645.62
(-8.66%)
ACI
19,149.43
-1742.75
(-8.34%)
JSGBKTI
61,003.52
-4399.07
(-6.73%)
HBLTTI
18,098.90
06-03-2026
12.47
(0.07%)
MII30
19,001.65
-1404.44
(-6.88%)
Citi Pharma Ltd.
PHARMACEUTICALS
Rs.70.14
-7.79
(-10.00%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Mon, Mar 9, 2026 1:49 PM
REG
DFC
CSF
ODL
Open
73.07
High
73.07
Low
70.14
Volume
3,009,983
CIRCUIT BREAKER
70.14 — 85.72
DAY RANGE
70.14 — 73.07
52-WEEK RANGE ^
60.50 — 105.31
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
77.93
VAR
13.50
HAIRCUT
17.50
P/E Ratio (TTM) **
15.38
1-Year Change * ^
-21.68%
YTD Change * ^
-17.09%
Last update: Mon, Mar 9, 2026 1:44 PM
Open
73.48
High
73.48
Low
70.45
Close
70.45
Change
-10.00%
LDCP
78.28
Volume
387,000
Total Trades
319
CIRCUIT BREAKER
70.45 — 86.11
DAY RANGE
70.45 — 73.48
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Mon, Mar 2, 2026 1:35 PM
Open
0.00
High
0.00
Low
0.00
Close
78.01
Change
0.00%
LDCP
79.41
Volume
0
Total Trades
1
CIRCUIT BREAKER
71.47 — 87.35
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Feb 1, 2026 3:49 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
79.41
Volume
0
Total Trades
0
CIRCUIT BREAKER
71.47 — 87.35
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Dec 28, 2025 3:06 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
78.53
Volume
0
Total Trades
0
CIRCUIT BREAKER
70.68 — 86.38
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Mar 1, 2026 2:45 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
80.51
Volume
0
Total Trades
0
CIRCUIT BREAKER
72.46 — 88.56
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.

KEY PEOPLE
Rizwan AhmadCEO
Nadeem AmjadChairperson
Ghulam DastgeerCompany Secretary
ADDRESS

3-KM, Head Balloki Road, Bhai Pheru, Distt Kasur

WEBSITE

www.citipharma.com.pk

REGISTRAR

F.D Registrar Services (Pvt.) Ltd.

AUDITOR

Aslam Malik & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
16,024,268.57
Shares
228,461,200
Free Float
114,230,600
Free Float
50.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Feb 18, 2026Transmission of Quarterly Financial Statements for the Period Ended 2025-12-31 View   PDF
Feb 13, 2026Financial Results for the Quarter Ended December 31, 2025 View   PDF
Oct 30, 2025TRANSMISSION OF QUARTERLY REPORT FOR THE PERIOD ENDED View   PDF
Oct 29, 2025Financial Results for the Quarter Ended View   PDF
Oct 7, 2025Transmission of Annual Report for the Year Ended View   PDF
DateTitleDocument
Feb 3, 2026Board meeting View   
Feb 3, 2026Board Meeting
REVOKED
View   
Nov 13, 2025Certified True Copy of the Resolutions Passed in the Annual General Meeting View   PDF
Oct 29, 2025Board Meeting Other Than Financial Results (Post Election BOD Meeting) View   
Oct 24, 2025Board Meeting View   
DateTitleDocument
Mar 3, 2026Material Information View   PDF
Feb 27, 2026Presentation - Corporate Briefing Session View   PDF
Feb 27, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Feb 26, 2026Material Information View   PDF
Feb 26, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales13,153,52112,409,23912,396,9839,779,880
Profit after Taxation892,039833,464657,984635,884
EPS3.903.652.882.88
Q2 2026Q1 2026Q3 2025Q2 2025
Sales4,332,5663,370,2473,341,1083,534,432
Profit after Taxation404,334203,691220,375256,979
EPS1.770.890.961.12
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)15.3412.7812.1613.83
Net Profit Margin (%)6.786.725.316.50
EPS Growth (%)6.8526.74(20.88)
PEG3.140.29(0.54)

Payouts

Financial Reports